• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初诊骨髓增生异常综合征患者自然杀伤细胞水平低可能预示预后不良:一项回顾性队列研究

Low Levels of Natural Killer Cell in Newly Diagnosed Myelodysplastic Syndromes Patients May Confer Poor Prognosis: A Retrospective Cohort Study.

作者信息

Gong Shengping, Shi Cong

机构信息

Cancer Radiotherapy and Chemotherapy Center, the First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.

Laboratory of Stem Cell Transplantation, the First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315000, People's Republic of China.

出版信息

Cancer Manag Res. 2024 Jul 3;16:753-760. doi: 10.2147/CMAR.S469393. eCollection 2024.

DOI:10.2147/CMAR.S469393
PMID:38974093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11227877/
Abstract

BACKGROUND

Immune imbalance appears to have a critical role in tumor growth according to emerging research. Peripheral lymphocyte subsets are considered to reflect the systemic immune response and clinical prognosis. The prognostic value of lymphocyte subpopulations in myelodysplastic syndrome (MDS) patients remains unclear.

METHODS

A total of 94 MDS patients were enrolled for the study. X-tile software was performed to determine the prognostic significance of various lymphocyte subpopulations, CD3, CD4, CD8, CD4/CD8 ratio, natural killer cell (NK) and CD19. Among them, the appropriate threshold of NK percent could be found only. Patients were divided into the high NK percent group and the low NK percent group. The prognostic significance was determined by univariate and multivariate Cox hazard models.

RESULTS

MDS patients with lower NK level had significantly shorter overall survival (OS). Based on univariate analysis, male gender ( = 0.030), lower HB (<10 g/dl, = 0.029), higher BM blast (>5%, < 0.0001), higher-risk IPSS-R cytogenetic ( = 0.032) and lower NK percent ( < 0.0001) were significantly associated with shorter OS. Multivariate Cox proportional hazards regression analysis indicated that low NK was also independent adverse prognostic factor for OS in MDS.

CONCLUSION

Decreased NK level predicts poor prognosis independent of the IPSS-R and provide a novel evaluation factor for MDS patients.

摘要

背景

根据最新研究,免疫失衡似乎在肿瘤生长中起关键作用。外周淋巴细胞亚群被认为可反映全身免疫反应和临床预后。骨髓增生异常综合征(MDS)患者淋巴细胞亚群的预后价值仍不明确。

方法

共纳入94例MDS患者进行研究。使用X-tile软件确定各种淋巴细胞亚群(CD3、CD4、CD8、CD4/CD8比值、自然杀伤细胞(NK)和CD19)的预后意义。其中,仅能找到NK百分比的合适阈值。患者被分为高NK百分比组和低NK百分比组。通过单因素和多因素Cox风险模型确定预后意义。

结果

NK水平较低的MDS患者总生存期(OS)明显较短。基于单因素分析,男性(P = 0.030)、较低的血红蛋白(<10 g/dl,P = 0.029)、较高的骨髓原始细胞比例(>5%,P < 0.0001)、较高风险的IPSS-R细胞遗传学(P = 0.032)和较低的NK百分比(P < 0.0001)与较短的OS显著相关。多因素Cox比例风险回归分析表明,低NK也是MDS患者OS的独立不良预后因素。

结论

NK水平降低预示着不良预后,独立于IPSS-R,并为MDS患者提供了一个新的评估因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2aa/11227877/de8abd696746/CMAR-16-753-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2aa/11227877/de8abd696746/CMAR-16-753-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2aa/11227877/de8abd696746/CMAR-16-753-g0001.jpg

相似文献

1
Low Levels of Natural Killer Cell in Newly Diagnosed Myelodysplastic Syndromes Patients May Confer Poor Prognosis: A Retrospective Cohort Study.初诊骨髓增生异常综合征患者自然杀伤细胞水平低可能预示预后不良:一项回顾性队列研究
Cancer Manag Res. 2024 Jul 3;16:753-760. doi: 10.2147/CMAR.S469393. eCollection 2024.
2
The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes.治疗前外周血炎症指标在骨髓增生异常综合征中的预后价值
Front Oncol. 2022 Apr 26;12:877981. doi: 10.3389/fonc.2022.877981. eCollection 2022.
3
Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes.血清载脂蛋白 A1 水平降低预示着初发骨髓增生异常综合征患者的预后不良。
BMC Cancer. 2022 Jan 31;22(1):127. doi: 10.1186/s12885-022-09248-2.
4
[Distribution of Natural Killer Cell in Patients with Newly Diagnosed Myelodysplastic Syndromes and Its Correlation with Prognosis].[初诊骨髓增生异常综合征患者自然杀伤细胞分布及其与预后的相关性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Feb;28(1):196-201. doi: 10.19746/j.cnki.issn.1009-2137.2020.01.033.
5
[Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome].再生障碍性贫血或低增生性骨髓增生异常综合征患者外周血淋巴细胞亚群分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Oct;24(5):1505-1510. doi: 10.7534/j.issn.1009-2137.2016.05.040.
6
Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome.高纤维蛋白原血症作为骨髓增生异常综合征的不良预后指标
Cancer Manag Res. 2022 Jun 4;14:1857-1865. doi: 10.2147/CMAR.S363568. eCollection 2022.
7
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.改良国际预后评分系统(IPSS-R)在前次异基因造血干细胞移植后并不能改善骨髓增生异常综合征患者的移植后结局:单中心经验。
Biol Blood Marrow Transplant. 2018 Jun;24(6):1209-1215. doi: 10.1016/j.bbmt.2018.02.007. Epub 2018 Feb 20.
8
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome.转甲状腺素蛋白降低预示原发性骨髓增生异常综合征预后不良。
Front Nutr. 2023 Mar 7;10:1125768. doi: 10.3389/fnut.2023.1125768. eCollection 2023.
9
[The Distribution and Significance of Activated T Cells and Lymphocyte Subsets in Myelodysplastic Syndrome].[活化T细胞及淋巴细胞亚群在骨髓增生异常综合征中的分布及意义]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Apr;31(2):469-475. doi: 10.19746/j.cnki.issn.1009-2137.2023.02.023.
10
The prognostic role of lymphocyte to monocyte ratio (LMR) in patients with Myelodysplastic Neoplasms.淋巴细胞与单核细胞比值(LMR)在骨髓增生异常肿瘤患者中的预后作用。
Hematology. 2023 Dec;28(1):2210929. doi: 10.1080/16078454.2023.2210929.

本文引用的文献

1
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.异基因造血细胞移植可改善高危遗传学亚组骨髓增生异常综合征的预后:血液和骨髓移植临床试验网络 1102 研究的遗传学分析。
J Clin Oncol. 2023 Oct 1;41(28):4497-4510. doi: 10.1200/JCO.23.00866. Epub 2023 Aug 22.
2
Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes.骨髓增生异常综合征中的骨髓免疫微环境
Cancers (Basel). 2022 Nov 17;14(22):5656. doi: 10.3390/cancers14225656.
3
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
世界卫生组织血液淋巴肿瘤分类第五版:髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
4
Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome.高纤维蛋白原血症作为骨髓增生异常综合征的不良预后指标
Cancer Manag Res. 2022 Jun 4;14:1857-1865. doi: 10.2147/CMAR.S363568. eCollection 2022.
5
Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes.血清载脂蛋白 A1 水平降低预示着初发骨髓增生异常综合征患者的预后不良。
BMC Cancer. 2022 Jan 31;22(1):127. doi: 10.1186/s12885-022-09248-2.
6
Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma.鼻咽癌患者治疗前循环淋巴细胞亚群的预后意义
Cancer Manag Res. 2021 Oct 27;13:8109-8120. doi: 10.2147/CMAR.S334094. eCollection 2021.
7
Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes.骨髓中成熟单核细胞升高,同时伴有较高的 IPSS-R 评分,预示骨髓增生异常综合征预后不良。
BMC Cancer. 2021 May 13;21(1):546. doi: 10.1186/s12885-021-08303-8.
8
Prognostic value of peripheral blood T lymphocyte subsets in clear cell renal cell carcinoma.外周血T淋巴细胞亚群在透明细胞肾细胞癌中的预后价值
Transl Androl Urol. 2021 Jan;10(1):326-335. doi: 10.21037/tau-20-1066.
9
The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.自然杀伤细胞及其配体在头颈部鳞状细胞癌中的预后作用:一项系统评价和荟萃分析。
Oncoimmunology. 2020 Apr 23;9(1):1747345. doi: 10.1080/2162402X.2020.1747345. eCollection 2020.
10
Prognostic value of peripheral blood natural killer cells in colorectal cancer.外周血自然杀伤细胞在结直肠癌中的预后价值
BMC Gastroenterol. 2020 Feb 7;20(1):31. doi: 10.1186/s12876-020-1177-8.